Efficacy and safety of semaglutide 2.4  mg according to antidepressant use at baseline: A post hoc subgroup analysis

CONCLUSIONS: In adults with overweight/obesity, semaglutide provided clinically meaningful weight loss regardless of baseline AD use, with an AE profile consistent with previous studies.PMID:37989717 | DOI:10.1002/oby.23946

Source: Obesity - November 21, 2023 Category: Eating Disorders & Weight Management Authors: Robert F Kushner Anders Fink-Jensen Ofir Frenkel Barbara McGowan Bryan Goldman Maria Overvad Thomas Wadden Source Type: research